Centene raises profit forecast betting on higher Medicaid premiums


June 17 (Reuters) – Health insurer Centene Corp (CNC.N) raised its forecast for full-year adjusted profit on Friday, betting on higher premiums from its government-backed Medicaid health insurance plans.

The company has performed well on the federal Obamacare marketplace – where it offers insurance plans – so far in the second quarter, it said in prepared remarks for its investor day.

It now expects a profit of $5.55 to $5.70 per share for the full year, compared with its earlier forecast of between $5.40 and $5.55 per share.

The company said its board has decided to increase its existing share buyback program by $3 billion and launch a $1 billion debt repurchase program, as the insurer prepares for the upcoming divestitures of two of its pharmacy businesses.

Centene said last month it would sell the units for about $2.8 billion as part of its strategy to exit the pharmacy benefit management space. read more

Reporting by Mrinalika Roy in Bengaluru; Editing by Aditya Soni



Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.



Read More:Centene raises profit forecast betting on higher Medicaid premiums

2022-06-17 11:57:00

Get real time updates directly on you device, subscribe now.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.